Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy

Melanoma Research

Volumn 7, Issue 1, 1997, Pages 10-18

  Heller, R ^b   Jaroszeski, M ^c   Perrott, R ^c   Messina, J ^a   Gilbert, R ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b University of South Florida   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

bleomycin; electrochemotherapy; electroporation and intratumour injection; melanoma

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROCHEMOTHERAPY; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION THERAPY; ELECTROMAGNETICS; FEMALE; INJECTIONS, INTRALESIONAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0031038607     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199702000-00003     Document Type: Article

References (41)

1. Coates AS. Systemic chemotherapy for malignant melanoma. World J Surg 1992; 16: 277-281.
2. Nathanson L, Jilani S. Chemotherapy of malignant melanoma. Cancer Treat Rev 1993; 19: 17-28.
3. Yeung RS. Management of recurrent cutaneous melanoma. Current Prob Cancer 1994; 18: 143-186.
4. Buzaid AC, Murren J. Chemotherapy for advances malignant melanoma. Int J Clin Lab Res 1992; 21: 205-220.
5. Balch CM, Houghton AN, Peters LJ. In: DeVita VT Jr. Hellman S, Rosenberg SA. eds. Cancer Principles and Practice of Oncology Table 46-47. Philadelphia: JB Lippincott Co. 1993; 1637.
6. Retsas S. Strategies for improving survival in malignant melanoma; focus on vindesine. J Drug Dev Clin Prac 1995; 7: 159-171.
7. Poddevin B, Orlowski S, Belehradek J Jr, Mir LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture, Biochem Parmacol 1991; 42(S): 67-75.
8. Tounekti O, Pron G, Belehradek J Jr, Mir LM. Bleomycin, an apaptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 1993; 53: 5462-5469.
9. Orlowski S, Belehradek J Jr. Paoletti C, Mir LM. Treatment electropermeabilization of cells in culture. Biochem Pharmacol 1988; 37: 4727-4733.
10. Chang DC, Chassy BM, Saunders JA, Sowers AE, (Ed). Guide to Electroporation and Electrofusion. San Diego, Academic Press, 1992.
11. Potter H. Electroporation in biology: methods, applications and instrumentation. Anal Biochem 1988; 174: 361-373.
12. Weaver JC. Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 1993; 51: 426-435.
13. Beledradek J Jr, Orlowski S, Ramirez LH, Pron G. Poddevin B, Mir LM. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta 1994; 1190: 155-163.
14. Powell KT, Morgenthaler AW, Weaver JC. Tissue electroporation: observation of reversible electrical breakdown in viable frog skin. Biophys J 1989; 56: 1163-1171.
15. Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acac Sci USA 1989; 90: 10504-10508.
16. Grasso RJ, Heller R, Cooley JC and Heller EM. Electrofusion of individual animal cells directly to intact corneal epithelial tissue. Biochim Biophys Acta 1989; 980(S): 9-14.
17. Heller R, Grasso RJ. Transfer of human membrane surface components by incorporating individual human cells into intact animal tissue by cell-tissue electrofusion in vivo. Biochim Biophys Acta 1990; 1024: 185-188.
18. Heller R, Gilbert R. Biological applications of cell-tissue electrofusion. In Chang DC, Chassy BM, Saunders JA, Sowers AK (Eds), Guide to Electroporation and Electrofusion. San Diego Academic Press. 1992: pp. 393-410.
19. Mir LM, Banoun H, Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988; 175: 15-25.
20. Orlowski S, Belehradek J Jr, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture Biochem Pharmacol 1988; 37: 4727-4733.
21. Mir LM, Belehradek M, Domenge C, Orlowski S. Poddevin J Jr, Schwab G, et al. Electrochemotherapy, a novel antitumour treatment: first clinical trial. C R Acad Sci Paris 1991; 313: 613-618.
22. Belehradek M, Domenge C, Luboinnski B, Orlowski S, Belehradek J, Mir LM. Electrochemotherapy, a new antitumour treatment: first clinical phase I-II trial. Cancer 1993; 72: 3694-3700.
23. Heller R. Treatment of cutaneous nodules using electrochemotherapy. J Florida Med Assoc 1995; 82: 147-150.
24. Glass LF, Fenske NA, Jaroszeski MJ, Perrott R, Harvey DT, Reintgen DS, et al. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol 1996; 34: 82-86.
25. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy: potentiation of antitumour effect of bleomycin of local electric pulses. Eur J Cancer 1991; 27: 68-72.
26. Belehradek J Jr, Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammory tumours in mice. Eur J Cancer 1991; 27: 73-76.
27. Okino M, Marumoto M, Kanesada H, Kuga K, Mohri H. Electrical impulse chemotherapy for rat solid tumours. Proc Jpn Cancer Congress 1987; 46: 420.
28. Okino M and Esato K. The effects of a single high voltage electrical stimulation with anticancer drug on in vitro growing malignant tumours. Jpn J Surg 1990; 20: 197-204.
29. Okino M, Tomie H, Kanesada H, Marumoto M, Morita N, Esato K, et al. Induction of tumour specific selective toxicity in electrical impulse chemotherapy - analysis of dose-response curve. Oncologia 1991; 24: 71-79.
30. Okino M, Tomie H, Kanesada H, Marumoto M, Esato K, Suzuki H. Optimal electric conditions in electrical impulse chemotherapy. Jpn J Cancer Res 1992; 83: 1095-1101.
31. Kanesda H. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma. J Jpn Soc Cancer Ther 1990; 25: 2640-2648.
32. Salford LG, Persson BRR, Brun A, Ceberg CP, Kongstad PC, Mir LM. A new brain tumour therapy combining bleomycin with in vitro electropermeabilization. Biochem Biophys Res Comm 1993; 194: 938-943.
33. Heller R, Jaroszeski M, Leo-Messina J, Perrot R, Van Voorhis N, Reintgen D, et al. Treatment of B16 melanoma with the combination of electroporation and chemotherapy. Bioelectrochem Bioenerget 1995; 36: 83-97.
34. Sersa G, Cemazar M, Miklavcic D, Mir LM. Electrochemotherapy: variable anti-tumour effect on different tumour models, Bioclectrochem Bioenerget 1994; 35: 25-27.
35. Yamaguchi O, Irisawa C, Baba K, Ogihara M, Yokota T, Shiraiwa Y. Potentiation of antitumour effect of bleomycin by local electric pulses in mouse bladder tumour. Tohoku J Exp Med 1994; 172: 291-293.
36. Dev SB, Hofmann GA. Electrochemotherapy - a novel method of cancer treatment. Cancer Treat Rev 1994; 20: 105-115.
37. Belehradek J Jr, Orlowski S, Ramirez LH, Pron G, Poddevin B, Mir LM. Electropermeabilization of cell in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta 1994; 1190: 155-163.
38. Auerbach R, Morrissey LW, Sidky YA. Regional differences in the incidence and growth of mouse tumours following intradermal of subcutaneous inoculation. Cancer Res 1978; 38: 1739-1744.
39. Mir LM, Roth C, Orlowski S, et al. Systemic antitumour effects of electrochemotherapy combined with histocompatible cells secreting interleukin-2. J Immunther 1995; 17: 30-38.
40. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr. Electrochemotherapy tumour treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Network 1992; 3: 331-334.
41. Mir LM, Roth C, Orlowski S, et al. Potentiation of the antitumoural effect of electrochemotherapy by an immunotherapy with allogenic cells producing interleukin-2. C R Acad Sci Paris (III) 1992; 314: 539-544.